查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1619479

2024 年癌症切片檢查全球市場報告

Cancer Biopsy Global Market Report 2024
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

癌症切片檢查市場規模預計在未來幾年將快速成長。到2028年，這一數字將以13.5%的年複合成長率（CAGR）成長至416.5億美元。預測期內的成長預測與患者人數的增加、老年人口的擴大、疑似乳癌病例的增加、癌症診斷的增加、切片檢查測試頻率的增加以及數量的增加有關的一般患者。這段時期的主要趨勢包括技術進步、人工智慧和機器學習的引入、多組體學整合、產品創新以及照護現場切片檢查設備的開發。

癌症發生率的增加預計將推動切片檢查市場的成長。由於生活方式的改變、都市化、環境污染、菸草和酒精的消費以及獲得醫療保健和認知的差異等因素，以異常細胞生長和擴散為特徵的癌症變得越來越普遍。癌症切片檢查透過從可疑區域取出並分析組織和細胞，對於診斷和評估癌症類型、分期和進展極為重要。例如，美國國家生物技術資訊中心報告稱，2023年1月，美國新增癌症病例1,958,310例，癌症相關死亡病例609,820例。此外，根據美國國家醫學圖書館2021年5月發布的報告，預計到2040年，全球癌症患者數將達到2,840萬，比2020年增加47%，死亡率也會隨之上升。盛行率的增加是推動切片檢查需求的關鍵因素。

癌症切片檢查市場的主要企業正在推進液體切片檢查技術，以實現癌症的非侵入性早期檢測和監測，從而改善患者的治療結果並實現更個人化的治療方法。液體切片檢查是一種先進的診斷方法，可分析血液樣本中的遺傳物質，包括循環腫瘤 DNA (ctDNA)、RNA、胞外體和其他生物標記。 2023 年 5 月，美國癌症切片檢查解決方案的領導者 Labcorp 推出了 Labcorp Plasma Focus，這是一種基於血漿的液體切片檢查，旨在檢測癌症相關的生物標記。 Plasma Focus 測試分析從血液中的癌細胞中提取的循環遊離 DNA (cfDNA)，以創建患者腫瘤的基因組圖譜，我們識別出與各種癌症（包括腫瘤）相關的 33 個基因的突變。

目錄

第1章執行摘要

第2章 市場特點

第3章 市場趨勢與策略

第4章宏觀經濟情景

  • 高通膨對市場的影響
  • 烏克蘭與俄羅斯戰爭對市場的影響
  • COVID-19 對市場的影響

第5章世界市場規模與成長

  • 全球癌症切片檢查市場：促進因素和限制因素
    • 市場促進因素
    • 市場限制因素
  • 全球癌症切片檢查市場表現：規模和成長，2018-2023
  • 全球癌症切片檢查市場預測：規模和成長，2023-2028 年、2033 年

第6章 市場細分

  • 全球癌症切片檢查市場：按類型、表現和預測，2018-2023、2023-2028、2033
  • 組織切片檢查
  • 液態生物檢體
  • 其他
  • 全球癌症切片檢查市場：按應用、性能和預測，2018-2023、2023-2028、2033
  • 乳癌
  • 大腸直腸癌
  • 子宮頸癌
  • 肺癌
  • 攝護腺癌
  • 皮膚癌
  • 血癌
  • 腎癌
  • 其他
  • 全球癌症切片檢查市場：按最終用戶、性能和預測，2018-2023、2023-2028、2033
  • 醫院
  • 診斷實驗室
  • 其他

第 7 章 區域/國家分析

  • 全球癌症切片檢查市場：按地區、績效和預測，2018-2023、2023-2028、2033
  • 全球癌症切片檢查市場：按國家、績效和預測，2018-2023、2023-2028、2033

第8章亞太市場

第9章 中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章 義大利市場

第20章 西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章加拿大市場

第26章 南美洲市場

第27章 巴西市場

第28章 中東市場

第29章 非洲市場

第30章 競爭格局及公司概況

  • 癌症切片檢查市場：競爭格局
  • 癌症切片檢查市場：公司簡介
    • Thermo Fisher Scientific Inc.
    • Danaher Corporation
    • Becton Dickinson and Company
    • Roche Diagnostics GmbH
    • Hologic Inc.

第31章 其他大型創新企業

  • Illumina Inc.
  • Bio-Rad Laboratories Inc.
  • QIAGEN NV
  • Exact Sciences Corporation
  • Myriad Genetics Inc.
  • Guardant Health Inc.
  • Veracyte Inc.
  • GRAIL Inc.
  • Freenome Holdings Inc.
  • Biodesix Inc.
  • Chronix Biomedical Inc.
  • Biocept Inc.
  • Personal Genome Diagnostics Inc.
  • Agena Bioscience Inc.
  • Oncimmune Holdings plc

第32章競爭基準化分析

第 33 章. 競爭對手儀表板

第34章 重大併購

第35章 未來展望與潛力分析

第36章附錄

簡介目錄
Product Code: r20510

A cancer biopsy is a medical procedure in which a small sample of tissue or cells is extracted from a suspicious area of the body to determine the presence of cancer or other conditions. This procedure is essential for diagnosing cancer, as imaging tests such as CT scans or MRIs cannot definitively differentiate between cancerous and non-cancerous cells.

The primary types of cancer biopsies include tissue biopsies, liquid biopsies, and others. Tissue biopsies involve extracting a small tissue sample from the body for microscopic examination. These procedures are used to diagnose various types of cancer, including breast, colorectal, cervical, lung, prostate, skin, blood, kidney, and other cancers. They are employed by different end users, such as hospitals, diagnostic laboratories, and other healthcare facilities.

The cancer biopsy market research report is one of a series of new reports from The Business Research Company that provides cancer biopsy market statistics, including cancer biopsy industry global market size, regional shares, competitors with a cancer biopsy market share, detailed cancer biopsy market segments, market trends, and opportunities, and any further data you may need to thrive in the cancer biopsy industry. This cancer biopsy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cancer biopsy market size has grown rapidly in recent years. It will grow from $22.12 billion in 2023 to $25.08 billion in 2024 at a compound annual growth rate (CAGR) of 13.4%. Growth during the historic period can be attributed to increased awareness of breast cancer liquid biopsy procedures, greater understanding of inherited oncology disorders and genetic testing, rising adoption of liquid biopsies, increased demand for minimally invasive biopsy treatments, and a growing demand for tissue biopsies.

The cancer biopsy market size is expected to see rapid growth in the next few years. It will grow to $41.65 billion in 2028 at a compound annual growth rate (CAGR) of 13.5%. The projected growth for the forecast period can be linked to an increasing patient population, an expanding elderly demographic, a higher number of suspected breast cancer cases, a rise in cancer diagnoses, more frequent biopsy testing, and a general increase in patient numbers. Key trends during this time include technological advancements, the incorporation of artificial intelligence and machine learning, the integration of multi-omics, product innovations, and the development of point-of-care biopsy devices.

The increasing incidence of cancer is expected to drive growth in the cancer biopsy market. Cancer, characterized by abnormal cell growth and spread, is becoming more prevalent due to factors such as lifestyle changes, urbanization, environmental pollution, tobacco and alcohol consumption, and disparities in healthcare access and awareness. Cancer biopsies are crucial for diagnosing and assessing cancer type, stage, and progression by extracting and analyzing tissue or cells from suspicious areas. For instance, the National Center for Biotechnology Information reported in January 2023 that the United States had 1,958,310 new cancer cases and 609,820 cancer-related deaths. Additionally, a May 2021 report from the National Library of Medicine forecasted a global cancer burden of 28.4 million cases by 2040, representing a 47% increase from 2020, along with a corresponding rise in mortality rates. This growing prevalence is a significant factor driving the demand for cancer biopsies.

Key players in the cancer biopsy market are advancing liquid biopsy technologies to enable non-invasive, early detection and monitoring of cancer, thereby improving patient outcomes and supporting more personalized treatment approaches. Liquid biopsy is an advanced diagnostic method that analyzes genetic material in blood samples, including circulating tumor DNA (ctDNA), RNA, exosomes, and other biomarkers. In May 2023, Labcorp, a US-based leader in cancer biopsy solutions, launched Labcorp Plasma Focus, a plasma-based liquid biopsy designed to detect cancer-related biomarkers. The Plasma Focus test analyzes circulating cell-free DNA (cfDNA) from tumor cells in the bloodstream to generate a genomic profile of the patient's tumor, identifying mutations across 33 genes associated with various cancers, including non-small cell lung cancer, colorectal cancer, breast cancer, esophageal cancer, and melanoma.

In June 2023, Quest Diagnostics, a US-based provider of diagnostic information services, acquired Haystack Oncology for up to $450 million. This acquisition aims to enhance Quest Diagnostics' expertise in cancer diagnostics, particularly in the detection of minimal residual disease (MRD). Haystack Oncology is a US-based company that specializes in liquid biopsy technology for cancer detection.

Major companies operating in the cancer biopsy market are Thermo Fisher Scientific Inc., Danaher Corporation, Becton Dickinson and Company, Roche Diagnostics GmbH, Hologic Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Exact Sciences Corporation, Myriad Genetics Inc., Guardant Health Inc., Veracyte Inc., GRAIL Inc., Freenome Holdings Inc., Biodesix Inc., Chronix Biomedical Inc., Biocept Inc., Personal Genome Diagnostics Inc., Agena Bioscience Inc., Oncimmune Holdings plc, Exosome Diagnostics Inc., Epigenomics AG, Genesystems Inc., Lucence Diagnostics Pte. Ltd., ANGLE plc

North America was the largest region in the cancer biopsy market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cancer biopsy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cancer biopsy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cancer biopsy market consists of sales of biopsy needles, biopsy guns, and biopsy punches. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cancer Biopsy Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cancer biopsy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cancer biopsy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cancer biopsy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Tissue Biopsies; Liquid Biopsies; Other Types
  • 2) By Application: Breast Cancer; Colorectal Cancer; Cervical Cancers; Lung Cancers; Prostate Cancers; Skin Cancers; Blood Cancers; Kidney Cancers; Other Applications
  • 3) By End User: Hospitals; Diagnostic Laboratories; Other End Users
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Danaher Corporation; Becton Dickinson and Company; Roche Diagnostics GmbH; Hologic Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cancer Biopsy Market Characteristics

3. Cancer Biopsy Market Trends And Strategies

4. Cancer Biopsy Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Cancer Biopsy Market Size and Growth

  • 5.1. Global Cancer Biopsy Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Cancer Biopsy Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Cancer Biopsy Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Cancer Biopsy Market Segmentation

  • 6.1. Global Cancer Biopsy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Tissue Biopsies
  • Liquid Biopsies
  • Other Types
  • 6.2. Global Cancer Biopsy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Breast Cancer
  • Colorectal Cancer
  • Cervical Cancers
  • Lung Cancers
  • Prostate Cancers
  • Skin Cancers
  • Blood Cancers
  • Kidney Cancers
  • Other Applications
  • 6.3. Global Cancer Biopsy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Diagnostic Laboratories
  • Other End Users

7. Cancer Biopsy Market Regional And Country Analysis

  • 7.1. Global Cancer Biopsy Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Cancer Biopsy Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Cancer Biopsy Market

  • 8.1. Asia-Pacific Cancer Biopsy Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Cancer Biopsy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Cancer Biopsy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Cancer Biopsy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Cancer Biopsy Market

  • 9.1. China Cancer Biopsy Market Overview
  • 9.2. China Cancer Biopsy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Cancer Biopsy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Cancer Biopsy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Cancer Biopsy Market

  • 10.1. India Cancer Biopsy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Cancer Biopsy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Cancer Biopsy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Cancer Biopsy Market

  • 11.1. Japan Cancer Biopsy Market Overview
  • 11.2. Japan Cancer Biopsy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Cancer Biopsy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Cancer Biopsy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Cancer Biopsy Market

  • 12.1. Australia Cancer Biopsy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Cancer Biopsy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Cancer Biopsy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Cancer Biopsy Market

  • 13.1. Indonesia Cancer Biopsy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Cancer Biopsy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Cancer Biopsy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Cancer Biopsy Market

  • 14.1. South Korea Cancer Biopsy Market Overview
  • 14.2. South Korea Cancer Biopsy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Cancer Biopsy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Cancer Biopsy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Cancer Biopsy Market

  • 15.1. Western Europe Cancer Biopsy Market Overview
  • 15.2. Western Europe Cancer Biopsy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Cancer Biopsy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Cancer Biopsy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Cancer Biopsy Market

  • 16.1. UK Cancer Biopsy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Cancer Biopsy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Cancer Biopsy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Cancer Biopsy Market

  • 17.1. Germany Cancer Biopsy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Cancer Biopsy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Cancer Biopsy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Cancer Biopsy Market

  • 18.1. France Cancer Biopsy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Cancer Biopsy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Cancer Biopsy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Cancer Biopsy Market

  • 19.1. Italy Cancer Biopsy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Cancer Biopsy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Cancer Biopsy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Cancer Biopsy Market

  • 20.1. Spain Cancer Biopsy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Cancer Biopsy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Cancer Biopsy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Cancer Biopsy Market

  • 21.1. Eastern Europe Cancer Biopsy Market Overview
  • 21.2. Eastern Europe Cancer Biopsy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Cancer Biopsy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Cancer Biopsy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Cancer Biopsy Market

  • 22.1. Russia Cancer Biopsy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Cancer Biopsy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Cancer Biopsy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Cancer Biopsy Market

  • 23.1. North America Cancer Biopsy Market Overview
  • 23.2. North America Cancer Biopsy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Cancer Biopsy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Cancer Biopsy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Cancer Biopsy Market

  • 24.1. USA Cancer Biopsy Market Overview
  • 24.2. USA Cancer Biopsy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Cancer Biopsy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Cancer Biopsy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Cancer Biopsy Market

  • 25.1. Canada Cancer Biopsy Market Overview
  • 25.2. Canada Cancer Biopsy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Cancer Biopsy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Cancer Biopsy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Cancer Biopsy Market

  • 26.1. South America Cancer Biopsy Market Overview
  • 26.2. South America Cancer Biopsy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Cancer Biopsy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Cancer Biopsy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Cancer Biopsy Market

  • 27.1. Brazil Cancer Biopsy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Cancer Biopsy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Cancer Biopsy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Cancer Biopsy Market

  • 28.1. Middle East Cancer Biopsy Market Overview
  • 28.2. Middle East Cancer Biopsy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Cancer Biopsy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Cancer Biopsy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Cancer Biopsy Market

  • 29.1. Africa Cancer Biopsy Market Overview
  • 29.2. Africa Cancer Biopsy Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Cancer Biopsy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Cancer Biopsy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Cancer Biopsy Market Competitive Landscape And Company Profiles

  • 30.1. Cancer Biopsy Market Competitive Landscape
  • 30.2. Cancer Biopsy Market Company Profiles
    • 30.2.1. Thermo Fisher Scientific Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Danaher Corporation
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Becton Dickinson and Company
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Roche Diagnostics GmbH
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Hologic Inc.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Cancer Biopsy Market Other Major And Innovative Companies

  • 31.1. Illumina Inc.
  • 31.2. Bio-Rad Laboratories Inc.
  • 31.3. QIAGEN N.V.
  • 31.4. Exact Sciences Corporation
  • 31.5. Myriad Genetics Inc.
  • 31.6. Guardant Health Inc.
  • 31.7. Veracyte Inc.
  • 31.8. GRAIL Inc.
  • 31.9. Freenome Holdings Inc.
  • 31.10. Biodesix Inc.
  • 31.11. Chronix Biomedical Inc.
  • 31.12. Biocept Inc.
  • 31.13. Personal Genome Diagnostics Inc.
  • 31.14. Agena Bioscience Inc.
  • 31.15. Oncimmune Holdings plc

32. Global Cancer Biopsy Market Competitive Benchmarking

33. Global Cancer Biopsy Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Cancer Biopsy Market

35. Cancer Biopsy Market Future Outlook and Potential Analysis

  • 35.1 Cancer Biopsy Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Cancer Biopsy Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Cancer Biopsy Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer